Insulin regulation of monoamine signaling: pathway to obesity
胰岛素对单胺信号传导的调节:肥胖途径
基本信息
- 批准号:8111663
- 负责人:
- 金额:$ 98.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-22 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AreaAttention Deficit DisorderBehaviorBipolar DisorderBrain regionCaloriesCognitionComorbidityComplexConsumptionCorpus striatum structureDevelopmentDietDietary PracticesDopamineEatingElementsEnvironmentFatty acid glycerol estersFeeding behaviorsFoodFoundationsGeneticGoalsHypothalamic structureImpaired cognitionIndividualInsulinInsulin ResistanceIntakeLeadLinkMidbrain structureModelingMolecularNeuronsObesityPathogenesisPathologyPopulationPreparationProcessPublic HealthRegulationRewardsRodent ModelRoleSchizophreniaSeminalSignal PathwaySignal TransductionStagingSyndromeSystemTherapeuticTimeWorkcombatdopaminergic neuronfeedingin vivoin vivo Modelinsightinsulin signalingmonoaminemouse modelnovel therapeutic interventionpublic health relevancesuccesssugartool
项目摘要
DESCRIPTION (provided by applicant): Modern dietary practices are out of control: despite knowing better, we consume too many calories, too much fat, and too much sugar. Herein we propose an idea that may explain our lack of success in combating obesity and that promises to transform our approach to this problem. This hypothesis arises from the recognized importance of midbrain dopamine signaling in complex aspects of food intake AND the seminal observation that insulin directly regulates dopamine signaling and reward. We propose that intact insulin signaling in midbrain areas such as striatum supports dopaminergic signaling and normal reward for food, which is adaptive when calories are scarce. In our modern, energy-dense food environment, reward drives poor dietary decisions. Reward-driven over-consumption of obesogenic foods quickly leads to neuronal insulin resistance and impaired dopamine signaling in striatum. In this stage the "hypodopaminergic reward deficiency syndrome" is established, in which decreased dopamine tone results in increased intake of obesogenic foods to achieve a normal level of reward in the setting of decreased dopamine tone. Our overarching hypothesis is that reward for food triggers midbrain insulin resistance, which sustains increased food intake, maladaptive feeding and behaviors, and as a consequence, obesity. Identification of the molecular mechanisms by which insulin fine-tunes control of feeding in the hypothalamus and reward centers in midbrain and identification of the mechanisms by which dysregulation of this system develops in obesity will yield tremendous insight. To achieve this goal, we will use a rodent model of diet-induced obesity in which dramatic changes in feeding behaviors occur. In this model a) for the first time we will quantify detailed pathological alterations in midbrain and hypothalamic insulin action and midbrain DA signaling over time, b) we will define the molecular mechanisms involved in these alterations in midbrain and hypothalamus using an array of cutting-edge tools, and c) as the model is refined and regulatory nodes identified, rescue the pathological alterations, proving the therapeutic potential of this work, and defining specific brain regions involved in obesity pathogenesis. We will initiate these studies in vivo, and will then model in vivo findings in ex vivo preparations, thereby distilling individual aspects of feeding regulation, a complex process involving cognition and reward. Finally, genetic tools in mouse models will illuminate the roles of insulin and dopamine signaling in the development of obesity in specific neuronal populations (e.g. dopamine neurons). Investigating this link between insulin and dopaminergic behavior will lay the foundation for understanding possible shared mechanisms of obesity and dopamine-related co- morbidities; cognitive dysfunction, bipolar disorder, schizophrenia, and attention-deficit disorder.
PUBLIC HEALTH RELEVANCE: Obesity and other dopamine-related pathologies such as schizophrenia, bipolar disorder, and attention-deficit disorder are a tremendous public health burden. Dopamine signaling has been identified as a key element of feeding behavior and insulin has recently been demonstrated to regulate dopamine tone. This proposal will analyze how parallel changes in insulin and dopamine signaling, induced by high-fat feeding cement changes in feeding behavior that lead to obesity and related co-morbidities and thereby allow the development of new therapeutic interventions.
描述(由申请人提供):现代饮食习惯已经失控:尽管我们了解得更多,但我们摄入了太多的卡路里、太多的脂肪和太多的糖。在此,我们提出了一个想法,可以解释我们在对抗肥胖方面缺乏成功的原因,并有望改变我们解决这个问题的方法。这一假设源于人们认识到中脑多巴胺信号传导在食物摄入的复杂方面的重要性,以及胰岛素直接调节多巴胺信号传导和奖励的开创性观察。我们认为,纹状体等中脑区域完整的胰岛素信号支持多巴胺能信号传导和对食物的正常奖励,这在卡路里稀缺时是适应性的。在我们现代、能量密集的食品环境中,奖励会导致不良的饮食决策。奖励驱动的过度食用致胖食物很快会导致神经元胰岛素抵抗和纹状体中的多巴胺信号受损。在这个阶段,“低多巴胺能奖赏缺乏综合征”成立,其中多巴胺张力降低导致肥胖食物的摄入量增加,以在多巴胺张力降低的情况下达到正常的奖赏水平。 我们的总体假设是,对食物的奖励会引发中脑胰岛素抵抗,从而导致食物摄入量增加、适应不良的喂养和行为,从而导致肥胖。 识别胰岛素微调下丘脑和中脑奖励中心摄食控制的分子机制,以及识别肥胖中该系统失调的机制,将产生巨大的洞察力。为了实现这一目标,我们将使用饮食诱发肥胖的啮齿动物模型,其中喂养行为会发生巨大变化。在该模型中,a)我们将首次量化中脑和下丘脑胰岛素作用以及中脑 DA 信号随时间的详细病理变化,b)我们将使用一系列尖端工具定义中脑和下丘脑这些变化所涉及的分子机制,c)随着模型的完善和调节节点的识别,挽救病理变化,证明该模型的治疗潜力 工作,并定义参与肥胖发病机制的特定大脑区域。我们将在体内启动这些研究,然后对离体制剂中的体内发现进行建模,从而提炼出摄食调节的各个方面,这是一个涉及认知和奖励的复杂过程。最后,小鼠模型中的遗传工具将阐明胰岛素和多巴胺信号传导在特定神经元群体(例如多巴胺神经元)肥胖发展中的作用。研究胰岛素和多巴胺能行为之间的这种联系将为理解肥胖和多巴胺相关并发症的可能共同机制奠定基础。认知功能障碍、双向情感障碍、精神分裂症和注意力缺陷障碍。
公共卫生相关性:肥胖和其他多巴胺相关疾病,如精神分裂症、双向情感障碍和注意力缺陷障碍,是巨大的公共卫生负担。多巴胺信号传导已被确定为进食行为的关键要素,最近已证明胰岛素可以调节多巴胺张力。该提案将分析高脂肪喂养引起的胰岛素和多巴胺信号传导的平行变化如何影响导致肥胖和相关并发症的喂养行为的变化,从而开发新的治疗干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AURELIO GALLI其他文献
AURELIO GALLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AURELIO GALLI', 18)}}的其他基金
The Role of the Dopamine Transporter in Psychostimulant Abuse
多巴胺转运蛋白在精神兴奋剂滥用中的作用
- 批准号:
10402705 - 财政年份:2021
- 资助金额:
$ 98.37万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
9601228 - 财政年份:2017
- 资助金额:
$ 98.37万 - 项目类别:
The Role of the Dopamine Transporter in Psychostimulant Abuse
多巴胺转运蛋白在精神兴奋剂滥用中的作用
- 批准号:
10527164 - 财政年份:2014
- 资助金额:
$ 98.37万 - 项目类别:
GLP-1 Receptors and Psychostimulant Addiction
GLP-1 受体和精神兴奋剂成瘾
- 批准号:
8840923 - 财政年份:2014
- 资助金额:
$ 98.37万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
8808750 - 财政年份:2014
- 资助金额:
$ 98.37万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
9755714 - 财政年份:2014
- 资助金额:
$ 98.37万 - 项目类别:
The Role of the Dopamine Transporter in Psychostimulant Abuse
多巴胺转运蛋白在精神兴奋剂滥用中的作用
- 批准号:
10529326 - 财政年份:2014
- 资助金额:
$ 98.37万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
9903264 - 财政年份:2014
- 资助金额:
$ 98.37万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
10545756 - 财政年份:2014
- 资助金额:
$ 98.37万 - 项目类别:
相似海外基金
PET STUDIES IN ATTENTION DEFICIT DISORDER: ROLE OF DOPAMINE
注意力缺陷障碍的宠物研究:多巴胺的作用
- 批准号:
7375392 - 财政年份:2005
- 资助金额:
$ 98.37万 - 项目类别:
PET STUDIES IN ATTENTION DEFICIT DISORDER: ROLE OF DOPAMINE
注意力缺陷障碍的宠物研究:多巴胺的作用
- 批准号:
7203667 - 财政年份:2004
- 资助金额:
$ 98.37万 - 项目类别:
PET studies in Attention Deficit Disorder: Role of Dopamine
注意力缺陷障碍中的 PET 研究:多巴胺的作用
- 批准号:
7044307 - 财政年份:2003
- 资助金额:
$ 98.37万 - 项目类别:
SEX AND AGE DIFFERENCES IN ATTENTION DEFICIT DISORDER
注意力缺陷障碍的性别和年龄差异
- 批准号:
6538382 - 财政年份:2002
- 资助金额:
$ 98.37万 - 项目类别:
AUTOMATED ASSESSMENT OF CHILD ATTENTION DEFICIT DISORDER
儿童注意力缺陷障碍的自动评估
- 批准号:
6403939 - 财政年份:2001
- 资助金额:
$ 98.37万 - 项目类别:
ADULTS W/ ATTENTION DEFICIT DISORDER: FAMILIAL & BEHAVIORAL DISORDERS
患有注意力缺陷障碍的成年人:家族性
- 批准号:
6491969 - 财政年份:2001
- 资助金额:
$ 98.37万 - 项目类别:
SEX AND AGE DIFFERENCES IN ATTENTION DEFICIT DISORDER
注意力缺陷障碍的性别和年龄差异
- 批准号:
6294921 - 财政年份:2001
- 资助金额:
$ 98.37万 - 项目类别:
ADULTS W/ ATTENTION DEFICIT DISORDER: FAMILIAL & BEHAVIORAL DISORDERS
患有注意力缺陷障碍的成年人:家族性
- 批准号:
6348140 - 财政年份:2000
- 资助金额:
$ 98.37万 - 项目类别:
ADULTS W/ ATTENTION DEFICIT DISORDER: FAMILIAL & BEHAVIORAL DISORDERS
患有注意力缺陷障碍的成年人:家族性
- 批准号:
6206110 - 财政年份:1999
- 资助金额:
$ 98.37万 - 项目类别:
TESTING THE VALIDITY OF ADULT ATTENTION DEFICIT DISORDER
测试成人注意力缺陷障碍的有效性
- 批准号:
2698824 - 财政年份:1998
- 资助金额:
$ 98.37万 - 项目类别: